National University of Singapore
Initial findings from the country's 10-year National Precision Medicine program could yield genetic tests tailored to Asian populations within Singapore and abroad.
Among NHL patients who received off-label therapy with combinations generated by the platform, nearly half achieved partial or complete responses.
The assay underwent clinical validation at three centers in Singapore and 5,248 patients were ultimately screened using the test.
Singapore's Avatamed Raises $1M in Seed Funding
Avatamed will use the funds to expand into the Asia-Pacific market and set up a lab in Singapore to provide precision cancer drug screening services.